Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2012 / Cilt: 22 - Sayı: 4

Topikal ankaferd hemostat’ın güvenilirliğini yansıtan sağlıklı gönüllülerde yapılmış plasebo kontrollü, randomize, çift kör, çapraz geçişli faz-I klinik çalışma

A placebo-controlled, randomized, double-blinded, cross-over phase-I clinical study indicating the safety of topical ankaferd hemostat in healthy volunteers

Pages
267–274
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Based on those data, it is concluded that topical application of ABS is safe and tolerable in humans.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ankaferd is a folkloric medicinal plant extract which has historically been used as an hemostatic agent in traditional Turkish medicine.
📊
Key Findings & Data:Twenty-four healthy volunteers (11 males and 13 females, aged 18-44 years) compatible with the study protocol were enrolled into the study.
💡
Conclusion & Impact:Based on those data, it is concluded that topical application of ABS is safe and tolerable in humans.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Ankaferd is a folkloric medicinal plant extract which has historically been used as an hemostatic agent in traditional Turkish medicine. Ankaferd Hemostat (ABS, Ankaferd BloodStopper®) includes the plants of Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum and Urtica dioica. The hemostatic effects of ABS have been established in the in vitro and in vivo studies in the Literature. The basic mechanism of action for ABS is the formation of an encapsulated protein network representing the focal points for the vital erythroid aggregation. The topical usage of ABS as a hemostatic agent in clinical hemorrhages and during dental interventions provided the first clues about the safety and efficacy of ABS in humans. The aim of this study is to search topical safety of ABS in a phase I randomized, double-blinded, cross-over, placebo controlled clinical study in healthy volunteers. Twenty-four healthy volunteers (11 males and 13 females, aged 18-44 years) compatible with the study protocol were enrolled into the study. In this study, topical ABS application for 120 minutes is not different from the placebo, in terms of both the local skin findings and systemic laboratory tests. Based on those data, it is concluded that topical application of ABS is safe and tolerable in humans.

Özet

Ankaferd, geleneksel Türk tıbbında hemostatik ajan olarak kullanılan bir bitkisel bileşiktir. Ankaferd Hemostat (ABS, Ankaferd Blood- Stopper®) Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum ve Urtica dioica bitkileri ABS içeriğinde yer almaktadır. ABS hemostatik etkileri, literatürde in vitro ve in vivo çalışmalarda gösterilmiştir. ABS’nin temel etki mekanizması, canlı eritroid aggregasyon için fokal odaklar teşkil eden bir protein ağının oluşturulmasına dayanmaktadır. Topikal ABS’nin insanlarda bir hemostatik ajan olarak etkinlik ve güvenilirliliğine ilişkin ilk bulgular, klinik kanamalar ve dental girişimlerdeki ABS kullanım verilerine dayanmaktadır. Bu çalışmanın amacı; randomize, çift-kör, çapraz geçişli, plasebo-kontrollü, bir çalışma ile sağlıklı gönüllülerde topikal ABS’nin güvenilirliliğini araştırmaktır. Yirmi dört sağlıklı gönüllü (11 erkek ve 13 kadın, 18-44 yaşlarında) çalışma protokolü ile uyumlu olarak çalışmaya alınmışlardır. Çalışma sonuçlarına göre 120 dakikalık topikal ABS uygulaması lokal cilt etkileri ve sistemik laboratuvar testleri yönünden plasebo uygulamasından farksız sonuçlar vermiştir. Bu verilere dayanarak insanlarda topikal ABS uygulamasının güvenilir olduğu sonucuna varılmıştır.

🔖

Cite This Article

BALÇIK, Ö. Ş., KÖROĞLU, M., CİPİL, H., KAFTAN, O., MARAl, S., GÜREL, A., GÖKER, H., HAZNEDAROĞLU, İ. C., KOŞAR, A. (2012). Topikal ankaferd hemostat’ın güvenilirliğini yansıtan sağlıklı gönüllülerde yapılmış plasebo kontrollü, randomize, çift kör, çapraz geçişli faz-I klinik çalışma. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 22 - Sayı: 4, 267–274. https://ajindex.com/articles/323274

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Haznedaroglu IC. Molecular basis of the pleiotropic effects of Ankaferd Blood Stopper. IUBMB Life 61: 290, 2009
  2. Goker H, Haznedaroglu IC, Ercetin S, et al. Haemostatic actions of the folkloric medicinal plant extract ankaferd blood Stopper (R). J Int Med Res 36: 163-170, 2008
  3. Haznedaroglu IC. Time to take a healthier view of history. Nature 396: 108, 1998
  4. Haznedaroglu IC, Goker H. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper (Response). J Int Med Res 36:1448-1449, 2008
  5. Beyazit Y, Kurt M, Kekilli M, et al. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 15: 329-336, 2010
  6. Akar N, Demiralp DO, Haznedaroglu IC, et al. Functional Proteomics of Ankaferd Blood Stopper. Blood 112: 4103, 2008
  7. Aydin S. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper (R). J Int Med Res 37: 279, 2009
  8. Karaman K, Celep B, Bostanci EB, et al. Effects of Ankaferd Blood Stopper on pancreatic fluid: An in vitro study. ANZ J Surg 80: 946-947, 2010
  9. Y›lmaz E, Gulec S, Haznedaroglu IC, et al. Effects of Ankaferd on HUVEC transcription factors and erythrocyte protein profile. In: Haznedaroglu IC, Goker H, Ozdemir O, et al., editors. Ankaferd: Scientific Perspectives and Basic-Clinical Data. Istanbul, Naviga Publications, 2008: 60
  10. Karabiyik A, Gulec S, Yilmaz E, et al. Reversible Protease- Activated Receptor I Downregulation Mediated by Ankaferd Blood Stopper Inducible With Lipopolysaccharides Inside the Human Umbilical Vein Endothelial Cells. Clin Appl Thromb Hemost 17: E165-170, 2011
  11. Odabafl ME, Erturk M, Cinar C, et al. Cytotoxicity of a new hemostatic agent on human pulp fibroblasts in vitro. Med Oral Patol Oral Cir Bucal 16: e584-7, 2011
  12. Arslan S, Haznedaroglu IC, Oz B, et al. Endobronchial application of Ankaferd blood stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Resp Med 2:144-146, 2009
  13. Erçetin S, Haznedaro¤lu IC, Kurt M, et al. Safety and efficacy of Ankaferd BloodStopper® in dental surgery and bleeding. UHOD 20: 1-5, 2010
  14. Koray M, Ergun S, Saruhanoglu A, et al. Use of a new local haemostatic agent Ankaferd blood stopper after surgical excision of eruption cyst: a case report. Int J Oral Maxillofacial Surg 38: 558, 2009
  15. Kurt M, Kacar S, Onal IK, et al. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial b